WallStreetZenWallStreetZen

NASDAQ: INDV
Indivior Pharmaceuticals Inc Stock Ownership - Who owns Indivior Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Indivior Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ryan PreblickChief Financial Officer2026-03-142,843$31.11
$88.45kSell
Barbara RyanDirector2026-03-138$31.09
$248.68Buy
Barbara RyanDirector2026-03-0931$32.56
$1.01kBuy
Stuart A. KingsleyDirector2026-03-06940$31.87
$29.95kBuy
Ryan PreblickChief Financial Officer2026-03-0387,597$31.98
$2.80MSell
Woodrow D. AndersonChief Accounting Officer2026-03-038,283$31.98
$264.89kSell
Woodrow D. AndersonChief Accounting Officer2026-03-032,682$31.98
$85.77kSell
Jeffrey W. BurrisChief Legal Officer2026-03-0336,032$31.98
$1.15MSell
Christian HeidbrederChief Scientific Officer2026-03-0345,797$31.98
$1.46MSell
Barbara RyanDirector2026-01-05775$35.39
$27.43kBuy

1 of 2

INDV insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INDV insiders and whales buy or sell their stock.

INDV Shareholders

What type of owners hold Indivior Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc14.58%18,230,539$571.16MInstitution
Oaktree Capital Management LP5.68%7,108,644$222.71MInstitution
Fuller Thaler Asset Management Inc5.09%6,371,534$199.62MInstitution
Madison Avenue Partners LP5.02%6,280,502$196.77MInstitution
Vanguard Group Inc4.38%5,473,891$171.50MInstitution
Two Seas Capital LP4.09%5,109,198$160.07MInstitution
State Street Corp3.73%4,659,281$145.98MInstitution
Morgan Stanley3.50%4,377,774$137.16MInstitution
Deerfield Management Company LP2.71%3,393,063$106.30MInstitution
Goldman Sachs Group Inc2.54%3,177,867$99.56MInstitution

1 of 3

INDV vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INDV97.13%0.74%Net SellingNet Selling
AMRX29.21%70.79%Net SellingNet Selling
ALKS93.52%6.48%Net SellingNet Selling
PBH69.13%30.87%Net SellingNet Selling
SUPN45.23%54.77%Net BuyingNet Selling
View Top Pharmaceutical Stocks

Indivior Pharmaceuticals Stock Ownership FAQ

Who owns Indivior Pharmaceuticals?

Indivior Pharmaceuticals (NASDAQ: INDV) is owned by 97.13% institutional shareholders, 0.74% Indivior Pharmaceuticals insiders, and 2.13% retail investors. Blackrock Inc is the largest individual Indivior Pharmaceuticals shareholder, owning 18.23M shares representing 14.58% of the company. Blackrock Inc's Indivior Pharmaceuticals shares are currently valued at $556.58M.

If you're new to stock investing, here's how to buy Indivior Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.